title: Role of positron emission tomography/computed tomography in bone malignancies.
abstract: This article presents an overview of positron emission tomography combined with computed tomography (PET/CT) imaging of bone tumors for the practicing radiologist. The clinical roles and utility of (18)F-labeled fluorodeoxyglucose PET/CT in patients with primary bone tumors, osseous metastases, and multiple myeloma are reviewed. The clinical and research data supporting the utility of PET/CT in the evaluation of skeletal malignancies continues to grow.
authors.affiliation: Nuclear Radiology, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA; Department of Radiology, College of Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. Electronic address: peller.patrick@mayo.edu.
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Peller
mesh_terms: D001706:Biopsy; D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D003287:Contrast Media; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000473:pathology; D064847:Multimodal Imaging; D009101:Multiple Myeloma / Q000000981:diagnostic imaging / Q000473:pathology; D009367:Neoplasm Staging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: Bony metastasis; Fluorodeoxyglucose; Multiple myeloma; Osteosarcoma; PET/CT; Positron emission tomography